Decitabine Followed by Partially Matched Related Bone Marrow Transplant and High-Dose Cyclophosphamide for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Decitabine (Primary) ; Cyclophosphamide; Mycophenolate mofetil; Tacrolimus
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 21 Nov 2019 Biomarkers information updated
- 06 Nov 2012 New trial record